Characteristics of the participants included in ABD gene expression analyses (with both nonmissing expression and phenotype data).

Values are means ± standard deviation for each quantitative variable.
*Individuals (N = 7) with treatment for lipid abnormalities or hypertension were assigned as having reduced HDL or raised blood pressure. T2D is defined as fasting blood glucose >7.0 mmol/l or antiglycemic treatment).